Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniel Walgenbach
Institution:
University of South Florida
Observed institution:
University of South Florida
OpenAlex ID:
A5115006866
Evolution of clonal hematopoiesis during cancer treatment and its impact on outcomes
2026
·
Mona Arabzadeh
, Yi-Han Tang
, et al.
·
Journal of Clinical Investigation
·
7
PDF
Real World Outcomes of Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia: A Single Center Experience
2024
·
Fatima Tuz Zahra
, Faustine Ong
, et al.
·
Blood
·
2
PDF
POSTER: ALL-1317: Outcomes After TKI Discontinuation in Patients With Ph+ ALL Treated With Blinatumomab and Ponatinib
2026
·
Abigail Huetteman
, Amin Azem
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
ORAL ABSTRACT: ALL-1317: Outcomes After TKI Discontinuation in Patients With Ph+ ALL Treated With Blinatumomab and Ponatinib
2026
·
Abigail Huetteman
, Amin Azem
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
ALL-1317: Outcomes After TKI Discontinuation in Patients With Ph+ ALL Treated With Blinatumomab and Ponatinib
2026
·
Abigail Huetteman
, Amin Azem
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-1252 Equitable Overall Survival in AML With Hypomethylating Agent and Venetoclax Despite Medically Underserved Area or Driving Distance: A Comparative Cohort Analysis Including Intensive Chemotherapy
2025
·
Daniel Walgenbach
, Fatima Tuz Zahra
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
AML-1252: Equitable Overall Survival in AML With Hypomethylating Agent and Venetoclax Despite Medically Underserved Area or Driving Distance: A Comparative Cohort Analysis Including Intensive Chemotherapy
2025
·
Daniel Walgenbach
, Fatima Tuz Zahra
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
7
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type
